Coeptis Therapeutics Holdings, Inc. - COEP
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Chief Financial Officer | A | A | 12,500.0 | 0.0 | 0.0 | 22,500.0 | View | |
| Feb 13, 2026 | Chief Financial Officer | M | A | 10,000.0 | 10.56 | 105,600.0 | 22,500.0 | View | |
| Feb 13, 2026 | — | A | A | 3,250.0 | 0.0 | 0.0 | 8,950.0 | View | |
| Feb 13, 2026 | — | M | A | 5,700.0 | 10.56 | 60,192.0 | 8,950.0 | View | |
| Feb 13, 2026 | — | A | A | 3,250.0 | 0.0 | 0.0 | 368,741.0 | View | |
| Feb 13, 2026 | — | M | A | 5,700.0 | 10.56 | 60,192.0 | 368,741.0 | View | |
| Feb 13, 2026 | CEO and President | A | A | 51,250.0 | 0.0 | 0.0 | 330,192.0 | View | |
| Feb 13, 2026 | CEO and President | M | A | 148,875.0 | 7.05 | 1,049,568.75 | 330,192.0 | View | |
| Feb 13, 2026 | — | A | A | 3,250.0 | 0.0 | 0.0 | 8,950.0 | View | |
| Feb 13, 2026 | — | M | A | 5,700.0 | 10.56 | 60,192.0 | 8,950.0 | View | |
| Feb 13, 2026 | VP Operations | A | A | 20,000.0 | 0.0 | 0.0 | 70,531.0 | View | |
| Feb 13, 2026 | VP Operations | M | A | 10,000.0 | 10.41 | 104,100.0 | 70,531.0 | View | |
| Feb 13, 2026 | — | A | A | 3,250.0 | 0.0 | 0.0 | 13,161.0 | View | |
| Feb 13, 2026 | — | M | A | 5,700.0 | 10.56 | 60,192.0 | 13,161.0 | View | |
| Feb 13, 2026 | — | A | A | 3,250.0 | 0.0 | 0.0 | 8,950.0 | View | |
| Feb 13, 2026 | — | M | A | 5,700.0 | 10.56 | 60,192.0 | 8,950.0 | View | |
| Feb 13, 2026 | VP Compliance and Secy | A | A | 12,500.0 | 0.0 | 0.0 | 64,031.0 | View | |
| Feb 13, 2026 | VP Compliance and Secy | M | A | 1,000.0 | 10.56 | 10,560.0 | 64,031.0 | View |